Open AccessPulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension
Author(s) -
Serpil Taş,
AUTHOR_ID,
A Antal,
Ali Durusoy,
Mehmed Yanartaş,
Kübra Yildiz Aydin,
Şehnaz Olgun Yıldızeli,
Derya Kocakaya,
Bülent Mutlu,
Fatma Alıbaz Öner,
Haner Diriskeneli,
Nevsun İnanç,
Atakan Erkılınç
Publication year - 2022
Publication title -
pubmed central
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.364
H-Index - 28
eISSN - 2149-2271
DOI - 10.5152/anatoljcardiol.2021.1138
Subject(s) - medicine , pulmonary hypertension , antiphospholipid syndrome , cardiology , thrombosis , endarterectomy , pulmonary artery , chronic thromboembolic pulmonary hypertension , surgery , stenosis
Antiphospholipid syndrome is an autoimmune disease characterized by the occurrence of venous and/or arterial thrombosis. Chronic thromboembolism is one of the known established pathogenesis of pulmonary hypertension, known as chronic thrombo-embolic pulmonary hypertension. Pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension. The aim of this study is to evalu-ate the efficacy and risk of pulmonary endarterectomy in patients with antiphospholipid syndrome-associated chronic thromboembolic pulmonary hypertension.